Relationship between doses of antihypertensive drugs and left ventricular mass index changes in hemodialysis patients in a Japanese cohort

References

• Pippias M, Jager KJ, Kramer A, et al. The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry. Nephrol Dial Transplant. 2016;31(5):831–841.
   PubMed Web of Science ®Google Scholar
• Foley RN, Parfrey PS. Cardiovascular disease and mortality in ESRD. J Nephrol. 1998;11(5):239–245.
   PubMed Web of Science ®Google Scholar
• Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol. 2001;12(5):1079–1084.
   PubMed Web of Science ®Google Scholar
• Mostovaya IM, Bots ML, van den Dorpel MA, et al. Left ventricular mass in dialysis patients, determinants and relation with outcome. Results from the convective transport study (CONTRAST). PLoS One. 2014;9(2):e84587.
   PubMed Web of Science ®Google Scholar
• Di Lullo L, Gorini A, Russo D, et al. Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment. Cardiorenal Med. 2015;5(4):254–266.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Wachtell K, Gerdts E, et al. Prognostic significance of left ventricular mass change during treatment of hypertension. Jama. 2004;292(19):2350–2356.
   PubMed Web of Science ®Google Scholar
• Zoccali C, Mallamaci F, Tripepi G, et al. Prediction of left ventricular geometry by clinic, predialysis and 24-h ambulatory BP monitoring in hemodialysis patients: CREED investigators. J Hypertens. 1999;17(12):1751–1758.
   PubMed Web of Science ®Google Scholar
• Foley RN, Curtis BM, Randell EW, et al. Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. Clin J Am Soc Nephrol. 2010;5(5):805–813.
   PubMed Web of Science ®Google Scholar
• Foley RN, Herzog CA, Collins AJ. Blood pressure and long-term mortality in United States Waves 3 and 4 Study. Kidney Int. 2002;62(5):1784–1790.
   PubMed Web of Science ®Google Scholar
• Conlon PJ, Walshe JJ, Heinle SK, et al. Predialysis systolic blood pressure correlates strongly with mean 24-h systolic blood pressure and left ventricular mass in stable hemodialysis patients. J Am Soc Nephrol. 1996;7(12):2658–2663.
   PubMed Web of Science ®Google Scholar
• Ok E, Asci G, Chazot C, et al. Controversies and problems of volume control and hypertension in haemodialysis. Lancet. 2016;388(10041):285–293.
   PubMed Web of Science ®Google Scholar
• Katzarski KS, Nisell J, Randmaa I, et al. A critical evaluation of ultrasound measurement of inferior vena cava diameter in assessing dry weight in normotensive and hypertensive hemodialysis patients. Am J Kidney Dis. 1997;30(4):459–465.
   PubMed Web of Science ®Google Scholar
• Ozkahya M, Ok E, Toz H, et al. Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant. 2006;21(12):3506–3513.
   PubMed Web of Science ®Google Scholar
• Meral K, Murat T, Mehmet O, et al. The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis. Nephrol Dial Transplant. 2009;24(3):956–962.
   PubMed Web of Science ®Google Scholar
• Takeda A, Toda T, Fujii T, et al. Can predialysis hypertension prevent intradialytic hypotension in hemodialysis patients? Nephron Clin Pract. 2006;103(4):c137–c143.
   PubMedGoogle Scholar
• Hirakata H, Nitta K, Inaba M, et al. Japanese society for dialysis therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis. Ther Apher Dial. 2012;16(5):387–435.
   PubMedGoogle Scholar
• WHO Collaborating Centre for Drug Statistics Methodology. Daily defined dose: definition and general considerations [online]; [cited 2013 Mar 16]. Available from http://www.whocc.no/ddd/definition_and_general_considera/.
   Google Scholar
• Modolo R, de Faria AP, Ritter AMV, et al. Defined daily dose (DDD) and its potential use in clinical trials of resistant hypertension. Int J Cardiol. 2016; 202:515–516.
   PubMed Web of Science ®Google Scholar
• Lang R, Bierig M, Devereux R, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440–1463.
   PubMed Web of Science ®Google Scholar
• Otterstad JE, Froeland G, St John Sutton M, et al. Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. Eur Heart J. 1997;18(3):507–513.
   PubMed Web of Science ®Google Scholar
• Callisaya ML, Sharman JE, Close J, et al. Greater daily defined dose of antihypertensive medication increases the risk of falls in older people-a population-based study. J Am Geriatr Soc. 2014;62(8):1527–1533.
   PubMed Web of Science ®Google Scholar
• Patel RK, Oliver S, Mark PB, et al. Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging. Clin J Am Soc Nephrol. 2009;4(9):1477–1483.
   PubMed Web of Science ®Google Scholar
• Sarak B, Wald R, Goldstein MB, et al. Relationship between changes in blood pressure and left ventricular mass over 1 year in end-stage renal disease. J Hypertens. 2017;35(8):1709–1716.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Metiku T, Tegegne GG, et al. Diagnosing hypertension by intradialytic blood pressure recordings. Clin J Am Soc Nephrol. 2008;3(5):1364–1372.
   PubMed Web of Science ®Google Scholar
• Hur E, Usta M, Toz H, et al. Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial. Am J Kidney Dis. 2013;61(6):957–965.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Nissenson AR, Batlle D, et al. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003;115(4):291–297.
   PubMed Web of Science ®Google Scholar
• Onofriescu M, Hogas S, Voroneanu L, et al. Bioimpedance-guided fluid management in maintenance hemodialysis: a pilot randomized controlled trial. Am J Kidney Dis. 2014;64(1):111–118.
   PubMed Web of Science ®Google Scholar
• Sinha AD, Light RP, Agarwal R. Relative plasma volume monitoring during hemodialysis AIDS the assessment of dry weight. Hypertension. 2010;55(2):305–311.
   PubMed Web of Science ®Google Scholar
• Rodriguez HJ, Domenici R, Diroll A, et al. Assessment of dry weight by monitoring changes in blood volume during hemodialysis using Crit-Line. Kidney Int. 2005;68(2):854–861.
   PubMed Web of Science ®Google Scholar
• Luik AJ, van Kuijk WH, Spek J, et al. Effects of hypervolemia on interdialytic hemodynamics and blood pressure control in hemodialysis patients. Am J Kidney Dis. 1997;30(4):466–474.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Bouldin JM, Light RP, et al. Inferior vena cava diameter and left atrial diameter measure volume but not dry weight. Clin J Am Soc Nephrol. 2011;6(5):1066–1072.
   PubMed Web of Science ®Google Scholar
• Joffy S, Rosner MH. Natriuretic peptides in ESRD. Am J Kidney Dis. 2005;46(1):1–10.
   PubMed Web of Science ®Google Scholar
• Aghogho O, Christopher M. Volume is not the only key to hypertension control in dialysis patients. Nephron Clin Pract. 2012;120(3):173–177.
   Google Scholar
• Khangura J, Culleton BF, Manns BJ, et al. Association between routine and standardized blood pressure measurements and left ventricular hypertrophy among patients on hemodialysis. BMC Nephrol. 2010;11:13.
   PubMed Web of Science ®Google Scholar